ClinicalOmics: Earlier this year, the Obama Administration launched the Precision
Medicine Initiative with a $215 million investment in the President’s
2016 Budget. Heralded as a bold new research effort to revolutionize how
we improve health and treat disease, the Precision Medicine Initiative
is intended to pioneer a new model of patient-powered research to
accelerate biomedical discoveries and provide clinicians with new tools,
knowledge, and therapies. Supporting the concept of precision medicine, preconception carrier
screening predicts the chances of having a child with specific genetic
disorders while diagnostic testing determines the cause of
pediatric-onset and other genetic disorders. Families can be started in both traditional and nontraditional ways;
preconception carrier screening provides the information needed for
prospective parents to figure out their preferred direction before
conception. Counsyl provides screening for diseases where advanced
knowledge makes a difference in health outcomes, whether it is changing a
behavior, pursuing preventive measures, or simply preparing for what
lies ahead.
